UnitedHealth (UNH) Gets a Buy From Oppenheimer
Positive Growth Trajectory and Robust Financial Health Reinforce Buy Rating for UnitedHealth
Barclays Maintains UnitedHealth(UNH.US) With Buy Rating, Maintains Target Price $655
George Hill's Buy Rating on UnitedHealth Driven by Investor Conference Insights and Optimistic 2025 Revenue Projections
Argus Adjusts Price Target on UnitedHealth Group to $670 From $600
UnitedHealth Group Analyst Ratings
Stephens & Co. Maintains Overweight on UnitedHealth Group, Raises Price Target to $675
UnitedHealth Price Target Raised to $625.00/Share From $595.00 by Deutsche Bank
UnitedHealth Is Maintained at Buy by Deutsche Bank
Deutsche Bank Raises Price Target on UnitedHealth Group to $625 From $595
UnitedHealth Is Maintained at Overweight by Barclays
UnitedHealth Group Analyst Ratings
Morgan Stanley Maintains UnitedHealth(UNH.US) With Buy Rating, Maintains Target Price $610
UnitedHealth's Strategic Outlook Reinforces Buy Rating Amidst Positive Medicare Insights and Growth Visibility
Barclays Maintains UnitedHealth(UNH.US) With Buy Rating, Raises Target Price to $655
RBC Capital Maintains UnitedHealth(UNH.US) With Buy Rating, Raises Target Price to $655
Barclays Maintains UnitedHealth(UNH.US) With Buy Rating, Maintains Target Price $603
Barclays Reaffirms Their Buy Rating on UnitedHealth (UNH)
Wells Fargo Maintains UnitedHealth(UNH.US) With Buy Rating, Raises Target Price to $677
Wells Fargo Adjusts Price Target on UnitedHealth to $677 From $630, Maintains Overweight Rating